ArcticZymes Technologies ASA (LTS:0DRV) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0DRV ArcticZymes Technologies ASA LTS:0DRV
76 GF Score
Price kr19.55
GF Value kr23.99
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0DRV
76GF Score
ArcticZymes Technologies ASA LTS:0DRV
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of kr19.55 is trading 18.5% below its estimated GF Value™ of kr23.99. GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.

Key valuation signals for LTS:0DRV:

  • Short Ratio:
  • GF Value™: kr23.99 vs. price of kr19.55 (18.5% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ArcticZymes Technologies ASA Business Description

Other Exchanges BIOTECO:SwedenAZT:Norway
Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
76GF Score

Get the complete analysis for LTS:0DRV

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr19.55
Price
kr23.99
GF Value